Clinipace
CRO Clinipace, has announced its new Executive VP of Global Medical Affairs.
Roger Morgan joins the company from Kowa Research Institute, where he was Chief Medical Officer and worked on cardiovascular, endocrine and ophthalmologic programmes, including the evaluation of preclinical molecules and potential in-licensing candidates in these areas. He has also served as Director of Medical Affairs for the Department of Surgery at Duke University, and as a Senior Director within the Internal Medicine Therapeutics Division of Quintiles.
In his latest role, Morgan will lead the global Medical Affairs department, including the cardiometabolic team, medical monitoring, and the pharmacovigilance and safety groups. He will provide senior medical oversight of clinical trials to ensure they follow both sponsor requirements and safety procedures.